Cargando…

Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study

BACKGROUND: Pegvaliase has allowed many adults with phenylketonuria (PKU) to achieve acceptable blood Phe control while eating an unrestricted diet. However, little is known about potential differences in nutritional status and eating behaviors after transitioning from a phenylalanine (Phe)-restrict...

Descripción completa

Detalles Bibliográficos
Autores principales: Viau, Krista, Martell, Leslie, Wessel, Ann, Rohr, Fran, Hollander, Suzanne, Putman, Melissa S., Sacharow, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694747/
http://dx.doi.org/10.1016/j.ymgmr.2023.101015
_version_ 1785153446631964672
author Viau, Krista
Martell, Leslie
Wessel, Ann
Rohr, Fran
Hollander, Suzanne
Putman, Melissa S.
Sacharow, Stephanie
author_facet Viau, Krista
Martell, Leslie
Wessel, Ann
Rohr, Fran
Hollander, Suzanne
Putman, Melissa S.
Sacharow, Stephanie
author_sort Viau, Krista
collection PubMed
description BACKGROUND: Pegvaliase has allowed many adults with phenylketonuria (PKU) to achieve acceptable blood Phe control while eating an unrestricted diet. However, little is known about potential differences in nutritional status and eating behaviors after transitioning from a phenylalanine (Phe)-restricted to an unrestricted diet. Here we assessed change in nutritional status in adults with early-treated PKU who were consuming a Phe-restricted diet (intact protein ≤0.8 g/kg/day) prior to starting pegvaliase. METHODS: A 15-month, prospective, longitudinal study to assess change in anthropometrics, dietary intake, laboratory indices of nutritional status, bone mineral density (BMD), body composition, measured resting energy expenditure (REE), and eating behaviors between baseline and Month 15. RESULTS: Eleven adults (n = 7 female) aged 19.5–52.9 years completed the study. Six participants had a substantial blood Phe reduction (responders) and five participants had a modest blood Phe reduction (partial responders) by Month 15. Intact protein intake increased by an average of 49.4 g/day and 26.7 g/day in responders and partial responders, respectively. Plasma concentrations of most vitamins, minerals, and essential fatty acids assessed were normal, though micronutrient intakes decreased as participants decreased or discontinued PKU medical food(s). Responders had a more variable change in body mass index (BMI) and lean mass index (LMI) compared to partial responders, though there were no clear trends in BMD or body composition changes. Total protein intake was positively correlated with LMI. Responders, but not partial responders, self-reported increased in enjoyment of food and decreased food neophobia, uncontrolled eating, and emotional eating. DISCUSSION: Participants transitioning to an unrestricted diet while on pegvaliase maintained adequate nutritional status overall with no clinically significant changes in cardiovascular or glycemic markers. Responders reported improvements in eating behaviors, including reduced food neophobia, uncontrolled eating, and emotional eating, and increased enjoyment of food. There were no consistent trends in BMD, body composition, or BMI changes. A larger sample size and longer follow-up period are needed to further assess potential changes.
format Online
Article
Text
id pubmed-10694747
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106947472023-12-05 Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study Viau, Krista Martell, Leslie Wessel, Ann Rohr, Fran Hollander, Suzanne Putman, Melissa S. Sacharow, Stephanie Mol Genet Metab Rep Research Paper BACKGROUND: Pegvaliase has allowed many adults with phenylketonuria (PKU) to achieve acceptable blood Phe control while eating an unrestricted diet. However, little is known about potential differences in nutritional status and eating behaviors after transitioning from a phenylalanine (Phe)-restricted to an unrestricted diet. Here we assessed change in nutritional status in adults with early-treated PKU who were consuming a Phe-restricted diet (intact protein ≤0.8 g/kg/day) prior to starting pegvaliase. METHODS: A 15-month, prospective, longitudinal study to assess change in anthropometrics, dietary intake, laboratory indices of nutritional status, bone mineral density (BMD), body composition, measured resting energy expenditure (REE), and eating behaviors between baseline and Month 15. RESULTS: Eleven adults (n = 7 female) aged 19.5–52.9 years completed the study. Six participants had a substantial blood Phe reduction (responders) and five participants had a modest blood Phe reduction (partial responders) by Month 15. Intact protein intake increased by an average of 49.4 g/day and 26.7 g/day in responders and partial responders, respectively. Plasma concentrations of most vitamins, minerals, and essential fatty acids assessed were normal, though micronutrient intakes decreased as participants decreased or discontinued PKU medical food(s). Responders had a more variable change in body mass index (BMI) and lean mass index (LMI) compared to partial responders, though there were no clear trends in BMD or body composition changes. Total protein intake was positively correlated with LMI. Responders, but not partial responders, self-reported increased in enjoyment of food and decreased food neophobia, uncontrolled eating, and emotional eating. DISCUSSION: Participants transitioning to an unrestricted diet while on pegvaliase maintained adequate nutritional status overall with no clinically significant changes in cardiovascular or glycemic markers. Responders reported improvements in eating behaviors, including reduced food neophobia, uncontrolled eating, and emotional eating, and increased enjoyment of food. There were no consistent trends in BMD, body composition, or BMI changes. A larger sample size and longer follow-up period are needed to further assess potential changes. Elsevier 2023-10-20 /pmc/articles/PMC10694747/ http://dx.doi.org/10.1016/j.ymgmr.2023.101015 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Viau, Krista
Martell, Leslie
Wessel, Ann
Rohr, Fran
Hollander, Suzanne
Putman, Melissa S.
Sacharow, Stephanie
Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
title Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
title_full Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
title_fullStr Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
title_full_unstemmed Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
title_short Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
title_sort nutritional status of adults with phenylketonuria on pegvaliase: a 15-month prospective study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694747/
http://dx.doi.org/10.1016/j.ymgmr.2023.101015
work_keys_str_mv AT viaukrista nutritionalstatusofadultswithphenylketonuriaonpegvaliasea15monthprospectivestudy
AT martellleslie nutritionalstatusofadultswithphenylketonuriaonpegvaliasea15monthprospectivestudy
AT wesselann nutritionalstatusofadultswithphenylketonuriaonpegvaliasea15monthprospectivestudy
AT rohrfran nutritionalstatusofadultswithphenylketonuriaonpegvaliasea15monthprospectivestudy
AT hollandersuzanne nutritionalstatusofadultswithphenylketonuriaonpegvaliasea15monthprospectivestudy
AT putmanmelissas nutritionalstatusofadultswithphenylketonuriaonpegvaliasea15monthprospectivestudy
AT sacharowstephanie nutritionalstatusofadultswithphenylketonuriaonpegvaliasea15monthprospectivestudy